
Journal of Organic Chemistry p. 3197 - 3214 (2012)
Update date:2022-08-06
Topics:
Offermann, Daniel A.
McKendrick, John E.
Sejberg, Jimmy J. P.
Mo, Bingli
Holdom, Mary D.
Helm, Birgit A.
Leatherbarrow, Robin J.
Beavil, Andrew J.
Sutton, Brian J.
Spivey, Alan C.
The disruption of the human immunolobulin E-high affinity receptor I (IgE-FcεRI) protein-protein interaction (PPI) is a validated strategy for the development of anti asthma therapeutics. Here, we describe the synthesis of an array of conformationally constrained cyclic peptides based on an epitope of the A-B loop within the Cε3 domain of IgE. The peptides contain various tolan (i.e., 1,2-biarylethyne) amino acids and their fully and partially hydrogenated congeners as conformational constraints. Modest antagonist activity (IC50 ~660 μM) is displayed by the peptide containing a 2,2′-tolan, which is the one predicted by molecular modeling to best mimic the conformation of the native A-B loop epitope in IgE.
View MoreJinan YouCheng Pharmatech Co.,Ltd
Contact:+86-18653163205
Address:No.750, Shunhua Road, University Science Park, High-tech Zone, Jinan City
Shandong Jincheng Zhonghua Bio-pharmaceutical Co.,Ltd
Contact:+86-533-5415882
Address:Zichuan Economic Development Zone,Zibo City,Shandong Province,China
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
wuxi huabin bio-tech Co.,Ltd(expird)
Contact:86-0510-85133006
Address:hubin road NO157
AllyChem Co., Ltd., Dalian, China(BBChem)
Contact:+86-411-62313318/62313328
Address:No.5 of Jinbin Road, Jinzhou New District, Dalian City, Liaoning Province, P.R.China
Doi:10.1016/S0040-4039(01)80674-2
(1989)Doi:10.1021/cm202635w
(2011)Doi:10.1246/bcsj.66.245
(1993)Doi:10.1039/c0cc05454b
(2011)Doi:10.3987/COM-10-12099
(2011)Doi:10.1016/0008-6215(90)84223-H
(1990)